Derisone L Fort Respicap

Derisone L Fort Respicap is a combination inhaler specifically formulated for the management of asthma and chronic obstructive pulmonary disease (COPD). This dual-action inhaler combines an anti-inflammatory corticosteroid with a fast-acting bronchodilator, providing both long-term control and immediate relief from respiratory symptoms.

• Beclometasone (200 MCG) – an inhaled corticosteroid (ICS) that reduces airway inflammation, swelling, and irritation, helping to prevent asthma attacks and maintain lung health.

• Levosalbutamol (200 MCG) – a selective short-acting beta-2 agonist (SABA) that relaxes airway muscles, delivering rapid relief from wheezing, breathlessness, and chest tightness.

This inhaler is ideal for patients with moderate to severe asthma or COPD who need both maintenance therapy and quick symptom relief, ensuring better lung function and improved quality of life.